Erlonat 150 Tablet (Erlotinib) – Treatment for Non-Small Cell Lung Cancer & Pancreatic Cancer

Erlonat 150 Tablet is a targeted anti-cancer medication containing Erlotinib, primarily used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to the kinase inhibitor class and works by blocking epidermal growth factor receptors (EGFR), which fuel cancer cell growth. This tablet must be taken on an empty stomach (1 hour before or 2 hours after meals) as prescribed by your doctor. While it may cause side effects like rash, nausea, or fatigue, its benefits in slowing cancer progression are significant. Always follow medical advice strictly to avoid severe complications.

Uses of Erlonat 150 Tablet:

• Treatment of non-small cell lung cancer (NSCLC).
• Management of pancreatic cancer, often combined with other therapies.

Benefits of Erlonat 150 Tablet:

In Non-Small Cell Lung Cancer (NSCLC), Erlonat 150 Tablet targets abnormal proteins to inhibit cancer cell multiplication. It is effective for both smokers and non-smokers. For pancreatic cancer, it improves survival rates when used alongside chemotherapy. Hydration and avoiding alcohol enhance its efficacy.

Side Effects of Erlonat 150 Tablet

Common side effects include nausea, vomiting, rash, fatigue, weight loss, and diarrhea. Severe reactions may include vision changes, mouth ulcers, or breathing difficulties. Report persistent symptoms to your doctor immediately.

How to Use Erlonat 150 Tablet?

Take 1 tablet daily on an empty stomach, as directed. Swallow whole—do not crush or chew. Maintain a consistent schedule for optimal results.

How Medicine Works?

Erlonat 150 Tablet blocks EGFR, a protein that promotes cancer cell growth. By inhibiting this pathway, it slows tumor progression and improves patient outcomes.

Safety Advice:

• Alcohol: Avoid—may increase side effects.
• Pregnancy/Breastfeeding: Unsafe. Use contraception during treatment.
• Liver/Kidney: Use cautiously; dose adjustments may be needed.
• Smoking: Reduces effectiveness. Quit before treatment.
• Sun Exposure: Wear sunscreen—medicine increases photosensitivity.

What If You Missed a Dose?

Skip the missed dose and resume the next scheduled dose. Do not double the dose to compensate.

FAQs:

Q1: How should Erlonat 150 Tablet be taken?

Take once daily on an empty stomach (1 hour before or 2 hours after meals) as prescribed. Swallow whole with water.

Q2: Is Erlonat 150 Tablet chemotherapy?

No, it’s a targeted therapy (kinase inhibitor) that blocks cancer cell signals, unlike traditional chemotherapy.

Q3: Can I smoke while taking Erlonat?

No. Smoking reduces its efficacy. Quit before starting treatment.

Q4: What if I develop a rash?

Rash is common. Use moisturizers, avoid sun exposure, and consult your doctor—do not stop the medicine.

Q5: Does Erlonat affect pregnancy?

Yes. Use contraception during treatment and for 1 month after the last dose.

Q6: Can it cause eye problems?

Yes—watch for dryness, redness, or vision changes. Inform your doctor immediately.